跳至主要内容
临床试验/EUCTR2007-007072-42-NL
EUCTR2007-007072-42-NL进行中(未招募)不适用

Double-blind placebo-controlled randomized study to determine the effectiveness of magnesium oxide to reduce the prostate motion. - Magnesium oxide to reduce prostate motion

niversity Medical Center Utrecht0 个研究点开始时间: 2008年1月10日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • Prostate cancer patients scheduled for external beam radiotherapy using fiducial marker-based position verification
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -Patients with known severe constipation
  • - Patients who receive laxantia
  • -Patients with a history of abdominal surgery
  • -Patients with known abdominal diseases (M. Crohn, colitis ulcerosa, diverticulitis )
  • -Patients with known severe renal failure
  • -Patients who receive tetracyclines, digoxine, iron or ciprofloxacine.
  • -Patients with known kidney stones

研究者

相似试验